Stopping GLP-1s raises cardiovascular risks: study

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy.

Hollie Adams | Reuters

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox.

Continue Reading


News Source: www.cnbc.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *